Fig. 2From: Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trialPlasma genistein concentration at baseline and after 12 months of genistein treatment. Boxes show adjusted means while confidence intervals are represented with error bars of n = 12–13 individualsBack to article page